Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

BioCorRx (BICX) Other Accumulated Expenses (2016)

BioCorRx (BICX) has disclosed Other Accumulated Expenses for 1 consecutive years, with $65000.0 as the latest value for Q4 2016.

Quarterly Other Accumulated Expenses changed N/A to $65000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Dec 2016, changed N/A year-over-year, with the annual reading at $65000.0 for FY2016, N/A changed from the prior year.
Other Accumulated Expenses hit $65000.0 in Q4 2016 for BioCorRx.
In the past five years, Other Accumulated Expenses ranged from a high of $65000.0 in Q4 2016 to a low of $65000.0 in Q4 2016.